With the fast progress and deeper understanding of CAR-T cell therapy, finding a better solution other than lentivirus transduction is more requested, to overcome the functional limitation on random insertion, uncontrolled copy number of CAR insertion and

09-28-2023 Dr. Lumeng Ye, Director of Novel Therapeutic Material Development, R&D Department, GenScript Biotech

Learn More

Join GenScript in this series of webinars, featuring 3 leaders in the life sciences from academia and industry, leveraging the strengths of synthetic biology technologies to develop life-changing therapies.

09-20-2023 Dr. John Zuris, Director of Editing Technologies – Editas Medicine

Learn More

Join us in our webinar to learn about optimizing enzyme manufacturing via an E. coli one-stop solution expression system, from enzyme discovery to conversion from RUO to GMP-grade requirements and facilitating a seamless transition

09-15-2023 Dr. Robert Ford, Field Application Scientist, GenScript Biotech - Europe

Learn More

Join us in our webinar to learn more about RNA therapeutics, optimization of mRNA stability and functionality, and the potentials of circular RNA as a novel class of therapeutics.

08-23-2023 Dr. Fengmei Pi, PhD, Head of RNA Biology at GenScript’s Innovation Center

Learn More

Towards nanopore proteomics: Enzyme-less single-molecule analysis of full-length proteins

08-11-2023 Dr. Yujia Qing Associate Professor of Organic Chemistry Department of Chemistry University of Oxford

Learn More

Join us in our webinar to learn more how our anti-idiotypic antibody platform can help you develop highly sensitive and specific polyclonal and monoclonal anti-ID antibodies to best suit your particular downstream applications with shorter turnaround time

05-18-2023 Dr. Hui Foon Tan, PhD, Sr. Global Product Manager - Antibody, GenScript Biotech

Learn More